AI Revolution and Validation Gap in Healthcare

AI is expanding across clinical care, drug discovery, laboratory automation, structural biology, and antimicrobial research, but clinical benefit remains insufficiently validated. Prospective and randomized evidence, real-world workflow evaluation, independent replication, and scrutiny of biosafety and unequal access remain essential; AI-designed bacteriophages are still limited to early laboratory evidence.